{"nct_id":"NCT03897881","title":"An Efficacy Study of Adjuvant Treatment With the Personalized Cancer Vaccine mRNA-4157 and Pembrolizumab in Participants With High-Risk Melanoma (KEYNOTE-942)","status":"RECRUITING","status_verified_date":"2025-06","start_date":"2019-07-18","start_date_type":"ACTUAL","primary_completion_date":"2029-09-09","primary_completion_date_type":"ESTIMATED","completion_date":"2029-09-09","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["MRNA"]}